I haven’t found an article yet that can actually articulate the problem with 23 and me right now, and actually did research into it or even read the terms and service. The problem with 23 and me is that they are not maximizing the share holder value of the data they are sitting on. The CEO wants to keep the company in line with the principals they were founded on which is to protect the privacy and data of their customers, while using opt in studies to build data sets that can be studied or sold.
Investors want to enshittify the company, and have been organizing a campaign against to company to try to drive it into liquidation to buy the data, even though the company is profitable. I wouldn’t be surprised is they are funding these weekly omfg 23 and me bad articles.
That juicy data is going to get bought up by the health insurance industry. I would be surprised if they aren’t part of the push to force them to sell the data.
I haven’t found an article yet that can actually articulate the problem with 23 and me right now, and actually did research into it or even read the terms and service. The problem with 23 and me is that they are not maximizing the share holder value of the data they are sitting on. The CEO wants to keep the company in line with the principals they were founded on which is to protect the privacy and data of their customers, while using opt in studies to build data sets that can be studied or sold.
Investors want to enshittify the company, and have been organizing a campaign against to company to try to drive it into liquidation to buy the data, even though the company is profitable. I wouldn’t be surprised is they are funding these weekly omfg 23 and me bad articles.
That juicy data is going to get bought up by the health insurance industry. I would be surprised if they aren’t part of the push to force them to sell the data.